• Valemetostat in Reliable Lymphoma Assays

  2026-08-11

  This scenario-based guide explains how Valemetostat (SKU BA4816) can be integrated into viability, proliferation, and cytotoxicity workflows without confusing biochemical potency with cellular response. It covers solvent compatibility, exposure design, EZH2-mutant comparisons, interpretation of lymphoma data, and practical product-selection criteria.

• BCL-XL inhibitor A-1155463 Workflow Guide

  2026-08-11

  Build more informative apoptosis assays with the selective BCL-XL inhibitor A-1155463, from DMSO stock preparation through orthogonal validation and in vivo translation. The workflow emphasizes functional BCL-XL dependence, resistance biology, and practical controls rather than relying on protein expression alone.

• ABT-888 (Veliparib) for DNA Repair Studies

  2026-08-10

  ABT-888 (Veliparib) is a selective PARP1/2 inhibitor for testing DNA repair inhibition alongside chemotherapy or radiation. Its strongest use-case is not a universal sensitizer claim, but a controlled platform for comparing genotype, treatment schedule, and tumor-model context.

• Imipramine in Cell Viability and Autophagy Research

  2026-08-09

  Learn how Imipramine, SKU BA2970, can support reproducible cell viability, autophagy, and apoptosis workflows when metabolic signals are interpreted alongside orthogonal measurements. This scenario-based guide covers assay design, concentration planning, storage, data analysis, and practical product selection for biomedical research.

• Dovitinib (TKI-258) Workflow for RTK Cancer Studies

  2026-08-08

  Dovitinib (TKI-258) enables pathway-focused studies that connect RTK blockade with proliferation, ERK/STAT signaling, and apoptosis. This workflow also translates a HER2-therapy-resistance study into practical assay design without overstating what has been experimentally demonstrated.

• GLI2, WNT, and Prostaglandins in ICB Resistance

  2026-08-07

  The reference study identifies GLI2 as a mechanistic link between mesenchymal transformation and tumor immune evasion, showing that GLI2 coordinates WNT ligand production with prostaglandin signaling. Its findings suggest that pathway-specific combinations, rather than GLI2-associated biology alone, may help reverse myeloid suppression and resistance to anti-PD-1 therapy.

• NU6300 Blocks Gasdermin D Pyroptosis via Cysteine-191 Target

  2026-08-07

  The reference study identifies NU6300 as a covalent inhibitor of gasdermin D (GSDMD), acting through direct modification of cysteine-191 to block GSDMD cleavage and palmitoylation. These findings elucidate a new regulatory mechanism for pyroptosis and suggest new therapeutic strategies for inflammatory diseases.

• Fingolimod (FTY720): S1P Modulation and Immunotherapy Integr

  2026-08-06

  Fingolimod (FTY720) is a potent, orally active S1P receptor modulator approved for multiple sclerosis. Its dual mechanism—lymphocyte egress inhibition and CNS neuroprotection—makes it a cornerstone for both clinical and experimental immunomodulation. Quantitative benchmarks and protocol parameters enable reliable deployment in translational immunology and emerging immune engineering workflows.

• AT-406 (SM-406): Advanced Apoptosis Activation in Cancer Res

  2026-08-06

  AT-406 (SM-406) stands out as a potent, orally bioavailable IAP antagonist, driving rapid and robust apoptosis pathway activation in diverse cancer models. This article delivers actionable guidance for experimental workflows, troubleshooting, and protocol optimization, with data-driven insights that empower researchers to harness AT-406 for enhanced sensitivity and reproducibility in oncology research.

• TRPV1+ Sensory Nerve Stimulation Suppresses Systemic Inflamm

  2026-08-05

  The referenced iScience study demonstrates that stimulating TRPV1+ peripheral somatosensory nerves, including with the capsaicin analog Nonivamide, rapidly suppresses systemic inflammation via a defined somato-autonomic reflex circuit. This work advances mechanistic understanding of neuroimmune interactions and provides a foundation for translational research targeting TRPV1 pathways.

• Griseofulvin (SKU B3680): Reliable Microtubule Disruption in

  2026-08-05

  This article provides practical, scenario-driven guidance for researchers using Griseofulvin (SKU B3680) as a microtubule associated inhibitor in cell viability and antifungal studies. Drawing on peer-reviewed evidence and workflow insights, it demonstrates how APExBIO’s high-purity Griseofulvin supports reproducible, high-content assays while addressing common laboratory challenges.

• Vitamin C (CAS 50-81-7): New Insights in Tumor Volume Reduct

  2026-08-04

  Discover how Vitamin C (ascorbic acid) advances cancer research through dose-dependent tumor volume reduction and apoptosis induction. This article delivers a fresh, mechanistic perspective, grounded in recent organoid and in vivo innovations.

• BH4 Oxidation Drives ERK1/2 Activation in Pain-Sensitized Ne

  2026-08-04

  This study uncovers how BH4 oxidation-derived H2O2, not BH4 itself, activates the B-Raf–MEK–ERK1/2 signaling cascade in rat dorsal root ganglion neurons, linking oxidative metabolism to neuronal sensitization in chronic pain. The findings reveal a new downstream target for pain modulation, with translational relevance for MEK-ERK pathway research.

• Practical Use of EdU Flow Cytometry Assay Kits (Cy5) for S-P

  2026-08-03

  The EdU Flow Cytometry Assay Kits (Cy5) offer a non-destructive, high-sensitivity approach to quantifying S-phase DNA synthesis and cell proliferation using click chemistry. This kit is well-suited for researchers seeking robust flow cytometry-based analysis of proliferation in diverse cell types, but it is not intended for applications requiring in situ tissue imaging or DNA denaturation-dependent protocols.

• EdU Cell Proliferation Kit (TMB): Precision S-Phase Analysis

  2026-08-03

  Explore how the EdU Cell Proliferation Kit enables precise, non-radioactive measurement of DNA synthesis during the S-phase, with in-depth analysis of assay optimization strategies and scientific advancements in rheumatoid arthritis research. Uncover what sets this 5-ethynyl-2'-deoxyuridine proliferation assay apart from traditional methods.

16266 records 1/1085 page Next 12345 下5页 Last page